GlassScriptPhysician profile
Robert B Flannery
NPI 1255514394
$27,309.73
in general payments reported to CMS, 2019-2025
46 companies · $5,270 in 2025
The $5,270 reported for 2025 was more than what 98% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $90.94 · 2021: $12K · 2022: $7,141 · 2023: $1,482 · 2024: $1,297 · 2025: $5,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,040 · Food and Beverage: $1,735 · Travel and Lodging: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,040.37 |
| Food and Beverage | $1,734.61 |
| Travel and Lodging | $273.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $13,653.69 | 2021-2025 | |
| Tenex Health INC. | $11,196.02 | 2019-2021 | |
| Djo, LLC | $347.19 | 2022-2025 | Aircast, Donjoy, Chattanooga |
| Bioventus LLC | $269.78 | 2019-2025 | Durolane, Gelsyn-3, Durolane |
| Biogen, INC. | $240.00 | 2021 | |
| Abbvie INC. | $148.77 | 2021-2024 | |
| Lilly USA, LLC | $118.90 | 2019-2023 | Trulicity, Humulin, Mounjaro |
| Merck Sharp & Dohme LLC | $89.20 | 2019-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Novo Nordisk INC | $84.73 | 2019-2024 | Ozempic, Rybelsus |
| Sanofi Pasteur INC. | $81.81 | 2020-2023 | |
| Amgen INC. | $80.06 | 2019-2023 | Prolia, Evenity |
| Ferring Pharmaceuticals INC. | $64.70 | 2019-2022 | |
| Amarin Pharma, INC. | $56.53 | 2019-2022 | |
| Exact Sciences Corporation | $55.11 | 2023-2025 | Cologuard Collection Kit |
| Hydrocision, INC. | $50.68 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Flannery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.